| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.045 | 0.8 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |